Publication | Open Access

Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors

Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacologyRational Drug DesignNew Substitution PatternDrug DevelopmentMolecular DockingPharmaceutical ChemistryDrug DiscoveryAntiangiogenesis Evaluation